Phase 1 × Leukemia × Bortezomib × Clear all
NCT01164709 2019-05-15

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

Swiss Cancer Institute

Phase 1 Completed
18 enrolled
NCT00006098 2013-06-18

PS-341 in Treating Patients With Hematologic Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
NCT00006362 2011-08-03

PS-341 in Treating Patients With Advanced Cancer

Mayo Clinic

Phase 1 Completed